Abstract
Pathogen-agnostic advanced molecular diagnostic testing for difficult-to-diagnose patients – results of an Emerging Infections Network survey of frontline U.S. Infectious Disease Clinicians, May 2023
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have